Open AccessSwitching From Oral Donepezil to Rivastigmine Transdermal Patch in Alzheimer’s Disease
Author(s) -
Carl Sadowsky,
Alan Dengiz,
Xiangyi Meng,
Jason T. Olin
Publication year - 2010
Publication title -
primary care companion to the journal of clinical psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1537-6699
pISSN - 1523-5998
DOI - 10.4088/pcc.09m00852oli
Subject(s) - rivastigmine , donepezil , tolerability , discontinuation , medicine , adverse effect , transdermal patch , transdermal , dementia , anesthesia , psychology , pharmacology , disease
To evaluate the long-term safety, tolerability, and efficacy of 2 strategies for switching from donepezil to rivastigmine transdermal patches in patients with mild to moderate Alzheimer's disease.